 Richard Reisdorph
Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 9 | 2020 | 527 | 1.270 |
Why?
| | Research | 2 | 2018 | 395 | 0.950 |
Why?
| | Mass Spectrometry | 9 | 2018 | 634 | 0.930 |
Why?
| | Proteomics | 6 | 2024 | 844 | 0.780 |
Why?
| | Proteome | 4 | 2023 | 339 | 0.700 |
Why?
| | Phosphopeptides | 1 | 2018 | 15 | 0.630 |
Why?
| | Metabolome | 2 | 2020 | 285 | 0.620 |
Why?
| | Peptide Mapping | 1 | 2018 | 60 | 0.620 |
Why?
| | Aldehyde Dehydrogenase | 4 | 2006 | 131 | 0.610 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2006 | 271 | 0.600 |
Why?
| | Tyrosine | 1 | 2018 | 216 | 0.590 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2018 | 370 | 0.510 |
Why?
| | Lung | 2 | 2018 | 3595 | 0.500 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 529 | 0.480 |
Why?
| | Chromatography, High Pressure Liquid | 5 | 2020 | 474 | 0.410 |
Why?
| | Bronchoalveolar Lavage Fluid | 5 | 2018 | 590 | 0.370 |
Why?
| | Chromatography, Liquid | 5 | 2024 | 348 | 0.360 |
Why?
| | Methylcholanthrene | 2 | 2006 | 18 | 0.320 |
Why?
| | Analgesia | 1 | 2010 | 82 | 0.320 |
Why?
| | Tandem Mass Spectrometry | 5 | 2024 | 413 | 0.320 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 323 | 0.260 |
Why?
| | Sirtuin 3 | 2 | 2023 | 52 | 0.240 |
Why?
| | Lipids | 2 | 2017 | 586 | 0.220 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 20 | 0.220 |
Why?
| | Corneal Injuries | 1 | 2024 | 34 | 0.220 |
Why?
| | Cholesterol | 2 | 2023 | 368 | 0.210 |
Why?
| | Acylation | 2 | 2019 | 28 | 0.200 |
Why?
| | Mustard Gas | 1 | 2024 | 117 | 0.200 |
Why?
| | Chemical Warfare Agents | 1 | 2024 | 120 | 0.200 |
Why?
| | Cysteine | 1 | 2023 | 171 | 0.200 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 318 | 0.200 |
Why?
| | Cell Hypoxia | 2 | 2003 | 220 | 0.200 |
Why?
| | Animals | 22 | 2024 | 31868 | 0.190 |
Why?
| | Sulfhydryl Compounds | 1 | 2023 | 177 | 0.190 |
Why?
| | Ion Mobility Spectrometry | 2 | 2017 | 5 | 0.190 |
Why?
| | Bronchoalveolar Lavage | 2 | 2018 | 84 | 0.190 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 24 | 0.180 |
Why?
| | Liquid-Liquid Extraction | 2 | 2018 | 15 | 0.180 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 133 | 0.170 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 83 | 0.170 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 10 | 0.170 |
Why?
| | Succinic Acid | 1 | 2019 | 44 | 0.170 |
Why?
| | Liposomes | 1 | 2020 | 146 | 0.170 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 168 | 0.170 |
Why?
| | Myofibrils | 1 | 2019 | 46 | 0.170 |
Why?
| | Biomarkers | 5 | 2023 | 3419 | 0.170 |
Why?
| | Cornea | 3 | 2024 | 107 | 0.160 |
Why?
| | Hypoxia | 2 | 2006 | 959 | 0.160 |
Why?
| | Ethanol | 2 | 2023 | 548 | 0.160 |
Why?
| | Organic Chemicals | 1 | 2020 | 114 | 0.160 |
Why?
| | Trypsin | 1 | 2018 | 67 | 0.160 |
Why?
| | Databases, Chemical | 1 | 2018 | 6 | 0.150 |
Why?
| | Food | 1 | 2020 | 160 | 0.150 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 236 | 0.150 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2016 | 965 | 0.150 |
Why?
| | Mitochondrial Proteins | 1 | 2019 | 220 | 0.150 |
Why?
| | DNA-Binding Proteins | 2 | 2003 | 1318 | 0.150 |
Why?
| | Autoantigens | 2 | 2011 | 397 | 0.150 |
Why?
| | Mitochondria | 2 | 2023 | 750 | 0.150 |
Why?
| | Mice | 13 | 2023 | 14928 | 0.140 |
Why?
| | Receptors, Aryl Hydrocarbon | 3 | 2003 | 39 | 0.140 |
Why?
| | Workflow | 1 | 2018 | 136 | 0.140 |
Why?
| | Cardiomyopathies | 1 | 2019 | 300 | 0.130 |
Why?
| | HEK293 Cells | 1 | 2018 | 590 | 0.130 |
Why?
| | Epitopes | 2 | 2016 | 436 | 0.130 |
Why?
| | Major Histocompatibility Complex | 1 | 2016 | 219 | 0.130 |
Why?
| | Phosphorylation | 2 | 2018 | 1572 | 0.130 |
Why?
| | C-Peptide | 1 | 2016 | 138 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2016 | 309 | 0.120 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2016 | 353 | 0.120 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 162 | 0.120 |
Why?
| | Myocardium | 1 | 2019 | 922 | 0.120 |
Why?
| | Xenobiotics | 2 | 2006 | 24 | 0.120 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2014 | 125 | 0.120 |
Why?
| | Galectins | 1 | 2013 | 22 | 0.110 |
Why?
| | Software | 2 | 2013 | 538 | 0.100 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2016 | 3247 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 1729 | 0.100 |
Why?
| | Humans | 18 | 2023 | 115052 | 0.100 |
Why?
| | Herpesviridae Infections | 1 | 2013 | 138 | 0.100 |
Why?
| | Pulmonary Emphysema | 1 | 2014 | 280 | 0.090 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2011 | 47 | 0.090 |
Why?
| | Hypersensitivity | 2 | 2017 | 256 | 0.090 |
Why?
| | Asthma | 2 | 2017 | 2051 | 0.090 |
Why?
| | Rats | 3 | 2006 | 4973 | 0.090 |
Why?
| | Killer Cells, Natural | 1 | 2013 | 383 | 0.090 |
Why?
| | Liver Neoplasms, Experimental | 2 | 2001 | 26 | 0.090 |
Why?
| | Computational Biology | 1 | 2013 | 533 | 0.090 |
Why?
| | Chromogranin A | 1 | 2010 | 39 | 0.080 |
Why?
| | Protein C | 1 | 2009 | 45 | 0.080 |
Why?
| | Epithelium, Corneal | 2 | 1999 | 37 | 0.080 |
Why?
| | Epithelial Cells | 2 | 2006 | 956 | 0.080 |
Why?
| | Tumor Cells, Cultured | 2 | 2001 | 851 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2013 | 3896 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 2716 | 0.070 |
Why?
| | Down-Regulation | 2 | 2001 | 599 | 0.070 |
Why?
| | Urinalysis | 2 | 2020 | 63 | 0.070 |
Why?
| | Smoking | 1 | 2014 | 1392 | 0.070 |
Why?
| | Heart Failure | 1 | 2019 | 1962 | 0.070 |
Why?
| | Mice, Inbred NOD | 3 | 2016 | 559 | 0.070 |
Why?
| | Luciferases | 1 | 2006 | 142 | 0.070 |
Why?
| | Response Elements | 1 | 2006 | 83 | 0.070 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 374 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 2016 | 1990 | 0.070 |
Why?
| | Genes, Reporter | 1 | 2006 | 257 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2010 | 668 | 0.060 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 817 | 0.060 |
Why?
| | RNA, Messenger | 2 | 2006 | 2563 | 0.060 |
Why?
| | Islets of Langerhans | 1 | 2011 | 729 | 0.060 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2003 | 15 | 0.060 |
Why?
| | Transcription Factors | 2 | 2003 | 1531 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2019 | 2585 | 0.060 |
Why?
| | Salmon | 1 | 2023 | 12 | 0.060 |
Why?
| | Seafood | 1 | 2023 | 16 | 0.060 |
Why?
| | Transcription Factor AP-1 | 1 | 2003 | 80 | 0.050 |
Why?
| | Actin Cytoskeleton | 1 | 2024 | 93 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1237 | 0.050 |
Why?
| | Click Chemistry | 1 | 2023 | 48 | 0.050 |
Why?
| | Rabbits | 1 | 2024 | 750 | 0.050 |
Why?
| | Acetylation | 1 | 2023 | 211 | 0.050 |
Why?
| | Dexamethasone | 1 | 2024 | 317 | 0.050 |
Why?
| | Actins | 1 | 2024 | 383 | 0.050 |
Why?
| | Tumor Suppressor Proteins | 1 | 2003 | 282 | 0.050 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 15 | 0.050 |
Why?
| | Sphingomyelins | 1 | 2020 | 27 | 0.050 |
Why?
| | Peptides | 2 | 2016 | 849 | 0.050 |
Why?
| | Inflammation Mediators | 1 | 2024 | 476 | 0.050 |
Why?
| | Cell Cycle | 1 | 2003 | 544 | 0.050 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 53 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 66 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 102 | 0.040 |
Why?
| | Up-Regulation | 1 | 2003 | 812 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 87 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2023 | 536 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2023 | 926 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 132 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 50 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2003 | 551 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 99 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2020 | 524 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 291 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 405 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 162 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 208 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 201 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 32 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2020 | 123 | 0.040 |
Why?
| | Species Specificity | 1 | 2020 | 548 | 0.040 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1998 | 107 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2016 | 2796 | 0.040 |
Why?
| | Cobalt | 1 | 1998 | 46 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2020 | 441 | 0.040 |
Why?
| | Liver Diseases, Alcoholic | 1 | 2019 | 84 | 0.040 |
Why?
| | Lysine | 1 | 2019 | 242 | 0.040 |
Why?
| | Flow Injection Analysis | 1 | 2017 | 5 | 0.040 |
Why?
| | Binding Sites | 1 | 2020 | 1173 | 0.040 |
Why?
| | Tissue Donors | 1 | 2019 | 326 | 0.040 |
Why?
| | Glycerophospholipids | 1 | 2017 | 26 | 0.040 |
Why?
| | Escherichia coli | 1 | 2020 | 719 | 0.040 |
Why?
| | Nerve Growth Factors | 1 | 2017 | 71 | 0.030 |
Why?
| | Proline | 1 | 2017 | 72 | 0.030 |
Why?
| | Sphingolipids | 1 | 2017 | 58 | 0.030 |
Why?
| | Diet | 1 | 2023 | 1076 | 0.030 |
Why?
| | Cell Line | 2 | 2017 | 2645 | 0.030 |
Why?
| | Germ Cells | 1 | 2016 | 57 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 123 | 0.030 |
Why?
| | Arginine | 1 | 2017 | 238 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 4718 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1423 | 0.030 |
Why?
| | Clone Cells | 1 | 2016 | 248 | 0.030 |
Why?
| | Male | 5 | 2023 | 55737 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 296 | 0.030 |
Why?
| | Protein Binding | 1 | 2020 | 1898 | 0.030 |
Why?
| | Neurons | 1 | 2023 | 1284 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2001 | 1085 | 0.030 |
Why?
| | Solid Phase Extraction | 1 | 2014 | 20 | 0.030 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 90 | 0.030 |
Why?
| | Blood Chemical Analysis | 1 | 2014 | 90 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2016 | 329 | 0.030 |
Why?
| | Blood Pressure | 1 | 2020 | 1539 | 0.030 |
Why?
| | Education | 1 | 2013 | 95 | 0.030 |
Why?
| | Muromegalovirus | 1 | 2013 | 13 | 0.030 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2013 | 26 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1624 | 0.030 |
Why?
| | Receptors, Virus | 1 | 2013 | 75 | 0.030 |
Why?
| | Interleukin-15 | 1 | 2013 | 75 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2013 | 196 | 0.030 |
Why?
| | Interleukin-12 | 1 | 2013 | 110 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2799 | 0.030 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 153 | 0.020 |
Why?
| | Signal Transduction | 1 | 2003 | 4525 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 50 | 0.020 |
Why?
| | Middle Aged | 2 | 2020 | 26831 | 0.020 |
Why?
| | alpha-2-HS-Glycoprotein | 1 | 2009 | 2 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2009 | 6 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 198 | 0.020 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 24 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 101 | 0.020 |
Why?
| | Haptoglobins | 1 | 2009 | 47 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1132 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1747 | 0.020 |
Why?
| | Albumins | 1 | 2009 | 89 | 0.020 |
Why?
| | Fibrinogen | 1 | 2009 | 155 | 0.020 |
Why?
| | Female | 3 | 2023 | 59619 | 0.020 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 107 | 0.020 |
Why?
| | Biomedical Research | 1 | 2013 | 585 | 0.020 |
Why?
| | Drug Interactions | 1 | 2009 | 347 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 843 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 233 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2013 | 1019 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1489 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2009 | 776 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2014 | 3545 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1715 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2003 | 69 | 0.010 |
Why?
| | Chickens | 1 | 2003 | 177 | 0.010 |
Why?
| | Proteins | 1 | 2009 | 915 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 257 | 0.010 |
Why?
| | Genome, Human | 1 | 2003 | 351 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 744 | 0.010 |
Why?
| | Transfection | 1 | 2003 | 872 | 0.010 |
Why?
| | Genomics | 1 | 2003 | 641 | 0.010 |
Why?
| | Eye Proteins | 1 | 1999 | 71 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2003 | 1145 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2003 | 1523 | 0.010 |
Why?
| | Young Adult | 1 | 2009 | 10498 | 0.010 |
Why?
| | Adult | 1 | 2009 | 30658 | 0.000 |
Why?
|
|
Reisdorph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|